[HTML] nature.com

[HTML][HTML] Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination

T Schmidt, V Klemis, D Schub, J Mihm, F Hielscher… - Nature medicine, 2021 - nature.com
Heterologous priming with the ChAdOx1 nCoV-19 vector vaccine followed by boosting with
a messenger RNA vaccine (BNT162b2 or mRNA-1273) is currently recommended in …
被引用次数：323 相关文章

Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination.

T Schmidt, V Klemis, D Schub, J Mihm, F Hielscher… - Nature …, 2021 - europepmc.org
Heterologous priming with the ChAdOx1 nCoV-19 vector vaccine followed by boosting with
a messenger RNA vaccine (BNT162b2 or mRNA-1273) is currently recommended in …

Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination

T Schmidt, V Klemis, D Schub, J Mihm… - Nature …, 2021 - pubmed.ncbi.nlm.nih.gov
Heterologous priming with the ChAdOx1 nCoV-19 vector vaccine followed by boosting with
a messenger RNA vaccine (BNT162b2 or mRNA-1273) is currently recommended in …
[HTML] nih.gov

[HTML][HTML] Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination

T Schmidt, V Klemis, D Schub, J Mihm… - Nature …, 2021 - ncbi.nlm.nih.gov
Heterologous priming with the ChAdOx1 nCoV-19 vector vaccine followed by boosting with
a messenger RNA vaccine (BNT162b2 or mRNA-1273) is currently recommended in …
[PDF] archive.org

[PDF][PDF] Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination

T Schmidt, V Klemis, D Schub, J Mihm, F Hielscher… - scholar.archive.org
Spike-specific IgGs were induced in 212/213 individuals after vaccination. IgG levels after
heterologous vaccination and homologous mRNA vaccination were similar (3,630 (IQR …

Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination

T Schmidt, V Klemis, D Schub, J Mihm… - 2021 - publikationen.sulb.uni-saarland.de
Heterologous priming with the ChAdOx1 nCoV-19 vector vaccine followed by boosting with
a messenger RNA vaccine (BNT162b2 or mRNA-1273) is currently recommended in …
[PDF] archive.org

[PDF][PDF] Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination

T Schmidt, V Klemis, D Schub, J Mihm, F Hielscher… - scholar.archive.org
Spike-specific IgGs were induced in 212/213 individuals after vaccination. IgG levels after
heterologous vaccination and homologous mRNA vaccination were similar (3,630 (IQR …

Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination.

T Schmidt, V Klemis, D Schub, J Mihm, F Hielscher… - Nature …, 2021 - europepmc.org
Heterologous priming with the ChAdOx1 nCoV-19 vector vaccine followed by boosting with
a messenger RNA vaccine (BNT162b2 or mRNA-1273) is currently recommended in …